Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

Proton Radiation Therapy for Gliomas

Status: Recruiting
Phase: Phase 2
Diagnosis: Radiation Oncology
NCT ID: NCT01358058 (View complete trial on
DFCI Protocol ID: 10-439


In this research study the investigators are looking at a type of radiation called proton radiation. Proton radiation has been shown to deliver virtually no radiation beyond the area of the tumor, sparing surrounding normal tissue from exposure. This may reduce side effects that patients would normally experience with conventional radiation therapy. In this research study the investigators are looking to determine if proton radiation with a reduced field size will be as effective in controlling tumor growth as photon therapy, while reducing the treatment-related side effects observed in patients with brain tumors.


Conducting Institutions:
Massachusetts General Hospital

Overall PI:
Helen Shih, MD, Massachusetts General Hospital

Site-responsible Investigators:

Massachusetts General Hospital: Cancer Trials Call Center, 877-789-6100

Eligibility Criteria

Inclusion Criteria: - Histologically confirmed low-grade gliomas OR Grade III anaplastic glioma with either or both IDH1 mutation or 1p/19q codeletion - Subject must be indicated for radiation therapy - Life expectancy greater than 5 years - Willing to participate in rigorous neurocognitive evaluations at baseline and serially following treatment - Able to speak and comprehend English - Recovered from adverse events due to agents administered more than 4 weeks before entering study - Able to undergo MRI scans Exclusion Criteria: - Prior cranial radiation therapy - Chemotherapy within 4 weeks prior to entering study - Pregnant or breastfeeding - Known brain metastases - Baseline neurocognitive or emotional disorders - Uncontrolled intercurrent illness - History of a different malignancy unless disease-free for at least 5 years - HIV positive on antiretroviral therapy
  •   Email
  •   Print
  •   Share
  • Make an Appointment

    • For adults:
      877-442-3324 (877-442-DFCI)

    • Quick access:
      Appointments as soon as the next day for new adult patients

    • For children:
      888-733-4662 (888-PEDI-ONC)

    • Make Appointment Online